Identiv, Inc.
Identiv, Inc. (INVE) Financial Performance & Income Statement Overview
Explore the financials of Identiv, Inc. (INVE), including yearly and quarterly data on income, cash flow, and balance sheets.
Identiv, Inc. (INVE) Income Statement & Financial Overview
Review Identiv, Inc. INVE income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.27M | $6.70M | $6.53M | $6.74M |
| Cost of Revenue | $5.14M | $7.69M | $6.29M | $6.13M |
| Gross Profit | $132000.00 | -$995000.00 | $238000.00 | $614000.00 |
| Gross Profit Ratio | $0.03 | -$0.15 | $0.04 | $0.09 |
| R&D Expenses | $787000.00 | $922000.00 | $1.10M | $966000.00 |
| SG&A Expenses | $4.55M | $4.17M | $8.69M | $6.37M |
| Operating Expenses | $5.34M | $5.63M | $9.79M | $7.33M |
| Total Costs & Expenses | $10.48M | $13.32M | $16.09M | $13.46M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $1.21M | $0.00 | $0.00 | $149000.00 |
| Depreciation & Amortization | $0.00 | $694000.00 | $652000.00 | $406000.00 |
| EBITDA | -$5.47M | -$6.11M | -$8.90M | -$6.37M |
| EBITDA Ratio | -$1.04 | -$0.91 | -$1.36 | -$0.95 |
| Operating Income | -$5.47M | -$6.63M | -$9.55M | -$6.72M |
| Operating Income Ratio | -$1.04 | -$0.99 | -$1.46 | -$1.00 |
| Other Income/Expenses (Net) | $682000.00 | $2.08M | $584000.00 | -$208000.00 |
| Income Before Tax | -$4.79M | -$4.55M | -$8.97M | -$6.93M |
| Income Before Tax Ratio | -$0.91 | -$0.68 | -$1.37 | -$1.03 |
| Income Tax Expense | -$3000.00 | -$271000.00 | $360000.00 | -$5000.00 |
| Net Income | -$4.79M | -$355000.00 | $85.95M | -$6.22M |
| Net Income Ratio | -$0.91 | -$0.05 | $13.16 | -$0.92 |
| EPS | -$0.21 | -$0.02 | $3.62 | -$0.27 |
| Diluted EPS | -$0.21 | -$0.02 | $3.62 | -$0.27 |
| Weighted Avg Shares Outstanding | $23.60M | $23.83M | $23.66M | $23.46M |
| Weighted Avg Shares Outstanding (Diluted) | $23.60M | $23.83M | $23.66M | $23.46M |
Over the past four quarters, Identiv, Inc. demonstrated steady revenue growth, increasing from $6.74M in Q2 2024 to $5.27M in Q1 2025. Operating income reached -$5.47M in Q1 2025, maintaining a consistent -104% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$5.47M, reflecting operational efficiency. Net income dropped to -$4.79M, with EPS at -$0.21. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan